Neurological Biomarkers Market Global Industry Analysis and Forecast (2024-2032)

Neurological Biomarkers Market Size Was Valued at USD 9.40 Billion in 2023, and is Projected to Reach USD 28.97 Billion by 2032, Growing at a CAGR of 13% From 2024-2032.
Neurological biomarkers are bio-active markers that may be detected in the brain, blood or cereal fluid to establish diagnosis of neurological disorders including Alzhiemers disease, Parkinson’s disease, Multiple sclerosis among other injuries.